|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:589-594, doi:10.1016/j.jacc.2004.10.061 © 2005 by the American College of Cardiology Foundation |
Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan
Manuscript received August 7, 2004; revised manuscript received September 23, 2004, accepted October 20, 2004.
* Reprint requests and correspondence: Dr. Hisao Ikeda, Department of Internal Medicine III, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan (Email: ikeda_hisao{at}kurume-u.ac.jp).
OBJECTIVES: We investigated whether and how soon smoking cessation ameliorates the smoking-induced intracellular oxidative stress and platelet aggregability in long-term smokers.
BACKGROUND: Smoking is a major risk factor of atherothrombosis. Smoking cessation reduces cardiac events. However, the underlying mechanisms of the beneficial effects remain to be elucidated.
METHODS: Twenty-seven male long-term smokers were divided into two groups. Group A (n = 14) quit smoking for four weeks whereas group B (n = 13) resumed smoking two weeks after quitting. Smoking status was monitored by measurement of urinary cotinine. Using gel-filtered platelets, agonist (adenosine diphosphate and collagen)-induced platelet aggregation, platelet-derived nitric oxide (PDNO), intraplatelet nitrotyrosine production, intraplatelet levels of the reduced form of glutathione (GSH) and its oxidized form (GSSG), and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and urinary 8-iso-prostaglandin F2
(8-iso-PGF2
), as markers of systemic oxidative stress, were measured. The baseline measurements were similar between the two groups.
RESULTS: Smoking cessation quickly reduced agonist-induced platelet aggregations, intraplatelet nitrotyrosine level, and urinary productions of 8-OHdG and 8-iso-PGF2
by two weeks in both groups. In group A, they were maintained at the low levels until four weeks, whereas they were reversed by resmoking in group B; PDNO release and intraplatelet GSH/GSSG ratio were time-dependently increased by smoking cessation but reversed by resmoking.
CONCLUSIONS: The present findings are the first demonstration that only two weeks of smoking cessation can ameliorate the enhanced platelet aggregability and intraplatelet redox imbalance in long-term smokers, possibly by decreasing oxidative stress. Our findings may strengthen the motivation for smokers to quit smoking.
| |||||||||||
This article has been cited by other articles:
![]() |
M. A. Brockmann, A. Giese, K. Mueller, F. j. Kaba, F. Lohr, C. Weiss, S. Gottschalk, I. Nolte, J. Leppert, J. Tuettenberg, et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma Neuro-oncol, July 1, 2007; 9(3): 335 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barone-Adesi, L. Vizzini, F. Merletti, and L. Richiardi Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction Eur. Heart J., October 2, 2006; 27(20): 2468 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hermann, H. Krum, and F. Ruschitzka To the Heart of the Matter: Coxibs, Smoking, and Cardiovascular Risk Circulation, August 16, 2005; 112(7): 941 - 945. [Full Text] [PDF] |
||||
![]() |
Smoking Cessation Improves Platelet Function in Just Two Weeks Journal Watch Cardiology, March 25, 2005; 2005(325): 7 - 7. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |